Discover open access scientific publications

Search, annotate, share and cite publications

Publications by B. Charbonnel

Efficacy and Safety Over 26 Weeks of an Oral Treatment Strategy Including Sitagliptin Compared With an Injectable Treatment Strategy With Liraglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin: A Randomised Clinical Trial

Diabetologia

English

Quantification of Human Cytoplasmic Islet-Cell Antibodies Which Cross-React With Mouse Pancreas: A Follow-Up Study in Type 1 (Insulin-Dependent) Diabetic Patients and in First-Degree Relatives

English

Related publications

Efficacy and Safety of Liraglutide Versus Sitagliptin, Both in Combination With Metformin, in Chinese Patients With Type 2 Diabetes: A 26-Week, Open-Label, Randomized, Active Comparator Clinical Trial

Diabetes, Obesity and Metabolism

English

Effects of Vildagliptin on Glucose Control Over 24 Weeks in Patients With Type 2 Diabetes Inadequately Controlled With Metformin

English

Efficacy and Safety of Diacerein in Patients With Inadequately Controlled Type 2 Diabetes: A Randomized Controlled Trial

English

Comparison of Nateglinide and Gliclazide in Combination With Metformin, for Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Maximum Doses of Metformin Alone

English

A Phase 3 Randomized Placebo-Controlled Trial to Assess the Efficacy and Safety of Ipragliflozin as an Add-On Therapy to Metformin in Russian Patients With Inadequately Controlled Type 2 Diabetes Mellitus

Diabetes Research and Clinical Practice

English

Cost-Effectiveness Analysis of Liraglutide Versus Sitagliptin or Exenatide in Patients With Inadequately Controlled Type 2 Diabetes on Oral Antidiabetic Drugs in Greece

English

Effect of Adding Insulin Degludec to Treatment in Patients With Type 2 Diabetes Inadequately Controlled With Metformin and Liraglutide: A Double-Blind Randomized Controlled Trial (BEGIN: ADD TO GLP-1 Study)

Diabetes, Obesity and Metabolism

English

A Randomized Clinical Trial of the Efficacy and Safety of Sitagliptin Compared With Dapagliflozin in Patients With Type 2 Diabetes Mellitus and Mild Renal Insufficiency: The CompoSIT-R Study

Diabetes, Obesity and Metabolism

English

Cost-Utility Analysis of Liraglutide Compared With Sulphonylurea or Sitagliptin, All as Add-On to Metformin Monotherapy in Type 2 Diabetes Mellitus

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by B. Charbonnel

Efficacy and Safety Over 26 Weeks of an Oral Treatment Strategy Including Sitagliptin Compared With an Injectable Treatment Strategy With Liraglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin: A Randomised Clinical Trial

Quantification of Human Cytoplasmic Islet-Cell Antibodies Which Cross-React With Mouse Pancreas: A Follow-Up Study in Type 1 (Insulin-Dependent) Diabetic Patients and in First-Degree Relatives

Related publications

Efficacy and Safety of Liraglutide Versus Sitagliptin, Both in Combination With Metformin, in Chinese Patients With Type 2 Diabetes: A 26-Week, Open-Label, Randomized, Active Comparator Clinical Trial

Effects of Vildagliptin on Glucose Control Over 24 Weeks in Patients With Type 2 Diabetes Inadequately Controlled With Metformin

Efficacy and Safety of Diacerein in Patients With Inadequately Controlled Type 2 Diabetes: A Randomized Controlled Trial

Comparison of Nateglinide and Gliclazide in Combination With Metformin, for Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Maximum Doses of Metformin Alone

A Phase 3 Randomized Placebo-Controlled Trial to Assess the Efficacy and Safety of Ipragliflozin as an Add-On Therapy to Metformin in Russian Patients With Inadequately Controlled Type 2 Diabetes Mellitus

Cost-Effectiveness Analysis of Liraglutide Versus Sitagliptin or Exenatide in Patients With Inadequately Controlled Type 2 Diabetes on Oral Antidiabetic Drugs in Greece

Effect of Adding Insulin Degludec to Treatment in Patients With Type 2 Diabetes Inadequately Controlled With Metformin and Liraglutide: A Double-Blind Randomized Controlled Trial (BEGIN: ADD TO GLP-1 Study)

A Randomized Clinical Trial of the Efficacy and Safety of Sitagliptin Compared With Dapagliflozin in Patients With Type 2 Diabetes Mellitus and Mild Renal Insufficiency: The CompoSIT-R Study

Cost-Utility Analysis of Liraglutide Compared With Sulphonylurea or Sitagliptin, All as Add-On to Metformin Monotherapy in Type 2 Diabetes Mellitus